Literature DB >> 24642368

Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.

Xiaoyin Huang1, Qian Sun1, Haijin Fu1, Xiaojun Zhou2, Xiaoxiang Guan3, Jinghua Wang4.   

Abstract

Extranodal natural killer (NK)/T-cell lymphoma, nasal type (ENKTL) is an increasingly recognized disease entity of aggressive tumor progression. The objective of this study was to investigate the clinical and prognostic significance of c-Myc and Ki-67 expression in ENKTL. Immunohistochemistry for c-Myc and Ki-67 was performed on tissue sections from 53 patients diagnosed with ENKTL, and their correlation with clinicopathologic variables was assessed. We also made a comparison between c-Myc positive and negative ENKTL on proliferation index (PI); and analyzed relationship between expression of c-Myc and Ki-67 index. The survival was analyzed by Kaplan-Meier product-limit method. Positive expression of c-Myc was shown in 64.2% of the patients, and high expression of Ki-67 was found in 66%. The PI in c-Myc-positive tumor cell was significantly higher than that in c-Myc-negative ones (P=0.005). The positive correlation between c-Myc expression and Ki-67 index was also found (r=0.454, P=0.001). Patients of c-Myc expression were shown to be associated with unfavorable overall survival (OS) and decreased progression free survival (PFS) (P=0.000 and 0.013, respectively). High expression of Ki-67 was also shown to be correlated with worse OS and PFS (P=0.014 and 0.016, respectively). And patients expression of c-Myc+/Ki-67 high had the worst OS and PFS (P=0.002 and 0.027, respectively). c-Myc may play an important role in the carcinogenesis of NK/T cell lymphoma by promoting cell proliferation. Both c-Myc expression and Ki-67 high expression in ENKTL patients may be valuable indicators for predicting the survival of ENKTL patients.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Extranodal NK/T-cell lymphoma; Ki-67; Prognosis; c-Myc

Mesh:

Substances:

Year:  2014        PMID: 24642368     DOI: 10.1016/j.prp.2014.02.004

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  7 in total

1.  Predictors of survival of natural killer/T-cell lymphoma, nasal type, in a non-Asian population: a single cancer centre experience.

Authors:  Jule Vásquez; Mariana Serrano; Lourdes Lopez; Cristian Pacheco; Shirley Quintana
Journal:  Ecancermedicalscience       Date:  2016-11-02

2.  A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.

Authors:  Rong Liang; Guang-Xun Gao; Jie-Ping Chen; Ji-Shi Wang; Xiao-Min Wang; Yun Zeng; Qing-Xian Bai; Tao Zhang; Lan Yang; Bao-Xia Dong; Hong-Tao Gu; Mi-Mi Shu; Cai-Xia Hao; Jian-Hong Wang; Na Zhang; Xie-Qun Chen
Journal:  Hematol Oncol       Date:  2016-10-10       Impact factor: 5.271

3.  Correlation between the clinicopathological features and prognosis in patients with extranodal natural killer/T cell lymphoma.

Authors:  Lin-Shu Zeng; Wen-Ting Huang; Tian Qiu; Ling Shan; Lei Guo; Jian-Ming Ying; Ning Lyu; Xiao-Li Feng
Journal:  Chronic Dis Transl Med       Date:  2017-12-13

4.  Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type.

Authors:  Jing-Hua Wang; Xi-Wen Bi; Peng-Fei Li; Zhong-Jun Xia; Hui-Qiang Huang; Wen-Qi Jiang; Yu-Jing Zhang; Liang Wang
Journal:  J Cancer       Date:  2017-02-25       Impact factor: 4.207

5.  Survival Analysis of Hepatosplenic T Cell Lymphoma: A Population-Based Study Using SEER.

Authors:  Yajun Li; Kailin Chen; Chaohui Zuo; Ruolan Zeng; Yizi He; Xiaoyan Chen; Ling Xiao; Hui Zhou
Journal:  Int J Gen Med       Date:  2021-11-17

6.  Association between c-Myc Expression with Clinicopathological Features in T And NK Cell Lymphomas.

Authors:  Nasrun Hasenan; Seoparjoo Azmel Mohd Isa; Faezahtul Arbaeyah Hussain
Journal:  Asian Pac J Cancer Prev       Date:  2021-12-01

7.  PRDM1 decreases sensitivity of human NK cells to IL2-induced cell expansion by directly repressing CD25 (IL2RA).

Authors:  Burcu Akman; Xiaozhou Hu; Xuxiang Liu; Tevfik Hatipoğlu; Hua You; Wing C Chan; Can Küçük
Journal:  J Leukoc Biol       Date:  2020-11-04       Impact factor: 4.962

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.